Managing postinduction hypotension: the jury is still out
Listen to this summary
The authors investigate whether preventive continuous norepinephrine infusion is more effective than reactive ephedrine bolus injections in managing postinduction hypotension during cardiac surgery. The EPITUBE trial found no significant difference in severe hypotension or postoperative outcomes between the two approaches, but design limitations hindered the ability to detect a treatment effect. The study concludes that while preventive norepinephrine infusion is safe and feasible, further research is necessary to assess its potential benefits in specific surgical populations.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from British journal of anaesthesia
View all →Mar 25, 2026 · British journal of anaesthesia
Perioperative neurocognitive disorders: the importance of global systemic interactions
Mar 18, 2026 · British journal of anaesthesia
Prediction and risk evaluation of delirium after surgery in older patients: development and internal validation of an algorithm from the prospective BioCog cohort study
Mar 18, 2026 · British journal of anaesthesia
Documenting videolaryngoscopy and tracheal intubation: time to blend old ways with the new?
Mar 13, 2026 · British journal of anaesthesia
Validation status of definitive airway management simulators: a systematic review
Mar 11, 2026 · British journal of anaesthesia
Responsibility cannot be abdicated: a mandate for Patient-Centred Precision Care in perioperative brain health
Mar 7, 2026 · British journal of anaesthesia
When optimising the operating theatre compromises anaesthetic safety: ambient lighting, human performance, and medication error risk
More in Anesthesiology
View all →Mar 25, 2026 · Critical care medicine
Economic and Regional Disparities in Critical Care Ultrasound Training, Equipment Access, and Implementation Barriers in China: A Nationwide Cross-Sectional Survey
Mar 25, 2026 · The New England journal of medicine
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide
Mar 24, 2026 · Lancet (London, England)
Proton beam therapy for oropharyngeal cancer (TORPEdO): a phase 3, randomised controlled trial
Mar 24, 2026 · Journal of addiction medicine
Evaluating Clinicians' Perspectives on Initiation of Medications for Opioid Use Disorder During Psychiatric Admissions
Mar 24, 2026 · Journal of addiction medicine
Stimulant-induced Psychosis: A Comparative Systematic Review and Meta-analysis of Psychotic Outcomes from Therapeutic and Nontherapeutic Use of Stimulants
Mar 24, 2026 · Journal of addiction medicine
A Case of 7-Hydroxymitragynine Use Disorder Treated With Buprenorphine
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


